Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)

NCT03134118 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

55

Enrollment

NETWORK

Sponsor class

Conditions

Thymoma Type B3
Thymic Carcinoma

Interventions

DRUG: Nivolumab

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]